Quanticyt: Karyometric analysis of bladder washing for patients with superficial bladder cancer

被引:34
作者
vanderPoel, HG
Witjes, JA
vanStratum, P
Boon, ME
Debruyne, FMJ
Schalken, JA
机构
[1] UNIV NIJMEGEN HOSP,DEPT UROL,NL-6500 HB NIJMEGEN,NETHERLANDS
[2] LEIDEN CYTOL & PATHOL LAB,NL-2301 GB LEIDEN,NETHERLANDS
关键词
D O I
10.1016/S0090-4295(96)00210-5
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objectives. Quantitative cytology by image-analysis techniques enables objective interpretation of nuclear features in light microscopic images. OUANTICYT, a quantitative karyometric cytology system, was used in the follow-up of patients with superficial bladder cancer. Methods. From 1992 to 1995, 4137 samples from 1412 patients were obtained, At 1-year follow-up after the initial bladder washing, a tumor recurrence rate of 21% was found. In this period, tumor progression to invasive disease occurred in 1.6% of patients. Scoring of tumor by the QUANTICYT system was based on two nuclear features: the 2c deviation index and the mean of a nuclear shape feature: MPASS. Results. The method was found to be reproducible and superior to visual cytologic interpretation. QUANTICYT analysis of the bladder washings resulted in a score of low, intermediate, and high risk. In a multivariate analysis, highest grade of earlier tumor and OUANTICYT risk score were the best predictors of tumor recurrence and progression. For the easy application of OUANTICYT analysis in daily routine, a report form that included patient history and DNA histogram was developed. Conclusions, QUANTICYT karyometric analysis of bladder-wash material proved a useful, clinically applicable grading tool in the follow-up of patients with superficial bladder cancer, with sufficient power to be used in decision-making in the individual patient.
引用
收藏
页码:357 / 364
页数:8
相关论文
共 32 条
[11]  
2-Y
[12]   PROPOSAL FOR CHANGES IN CYSTOSCOPIC FOLLOW-UP OF PATIENTS WITH BLADDER-CANCER AND ADJUVANT INTRAVESICAL CHEMOTHERAPY [J].
HALL, RR ;
PARMAR, MKB ;
RICHARDS, AB ;
SMITH, PH .
BMJ-BRITISH MEDICAL JOURNAL, 1994, 308 (6923) :257-260
[13]  
HORBARTH K, 1991, EUR UROL, V20, P93
[14]   PREDICTABILITY OF RECURRENT AND PROGRESSIVE DISEASE IN INDIVIDUAL PATIENTS WITH PRIMARY SUPERFICIAL BLADDER-CANCER [J].
KIEMENEY, LALM ;
WITJES, JA ;
HEIJBROEK, RP ;
VERBEEK, ALM ;
DEBRUYNE, FMJ .
JOURNAL OF UROLOGY, 1993, 150 (01) :60-64
[15]  
KLEIN FA, 1982, CANCER, V50, P389, DOI 10.1002/1097-0142(19820801)50:3<389::AID-CNCR2820500302>3.0.CO
[16]  
2-I
[17]   DIFFICULTIES IN EVALUATING URINARY SPECIMENS AFTER LOCAL MITOMYCIN THERAPY OF BLADDER-CARCINOMA [J].
KOSHIKAWA, T ;
LEYH, H ;
SCHENCK, U .
AKTUELLE UROLOGIE, 1991, 22 (04) :209-212
[18]   COMPUTER-BASED DIAGNOSTIC-ANALYSIS OF CELLS IN THE URINARY SEDIMENT [J].
KOSS, LG ;
BARTELS, PH ;
WIED, GL .
JOURNAL OF UROLOGY, 1980, 123 (06) :846-849
[19]  
KOSS LG, 1989, CANCER, V64, P916, DOI 10.1002/1097-0142(19890815)64:4<916::AID-CNCR2820640426>3.0.CO
[20]  
2-U